(R)-Benzyl (4-chloro-3-oxo-1-(phenylthio)butan-2-yl)carbamate

Catalog No. :
ACFKKB187
CAS No. :
159878-01-0
Molecular Formula :
C18H18ClNO3S
Molecular Weight :
363.87

IUPAC Name:(R)-Benzyl (4-chloro-3-oxo-1-(phenylthio)butan-2-yl)carbamate

(R)-Benzyl (4-chloro-3-oxo-1-(phenylthio)butan-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$183.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-Benzyl (4-chloro-3-oxo-1-(phenylthio)butan-2-yl)carbamate
IUPAC Name(R)-Benzyl (4-chloro-3-oxo-1-(phenylthio)butan-2-yl)carbamate
Molecular FormulaC18H18ClNO3S
Molecular Weight363.87
SMILESO=C(OCC1=CC=CC=C1)N[C@H](C(CCl)=O)CSC2=CC=CC=C2
InChI KeyGHOXYLYITXKSDS-INIZCTEOSA-N
Synonym(r)-phenylmethyl [3-chloro-2-oxo-1-[(phenylthio)methyl]-propyl]carbamate;(r)-(-)-3-(benzyloxycarbonylamino)-1-chloro-4-phenylthio-2-butanone;Z-D-Phe chloromethyl ketone;(R)-benzyl (4-chloro-3-oxo-1-(phenylthio)butan-2-yl)carbaMate;(R)-Phenylmethyl [3-chloro-2-oxo-1-[(phenylthio)methyl]-propyl]carbamate-4;Carbamic acid, N-[(1R)-3-chloro-2-oxo-1-[(phenylthio)methyl]propyl]-, phenylmethyl ester;Nelfinavir Impurity 4
CAS No.159878-01-0
PubChem CID10808734

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFKKB187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFKKB187 route product structure diagram
    ACFKKB187159878-01-0
Inquiry

2. ACFKKB187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFKKB187 route product structure diagram
    ACFKKB187159878-01-0
Inquiry

Comments (0)